EGF/EGFR signaling is hyperactive in a broad array of human cancers including malignant breast cancer, skin tumor, non-small cell lung cancer (NSCLC), colorectal cancer, and pancreatic cancer10. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.